Understanding MASH and Your Diagnosis

If you have recently been diagnosed with MASH, you may feel a mix of confusion and concern. It is often called a “silent” disease because it frequently develops without noticeable symptoms, only to be discovered during routine blood work or an ultrasound for an unrelated issue ^[1]. You might also be seeing new terms like MASLD and wonder what happened to the older names you may have heard before, like NAFLD or NASH. Note that normal liver enzymes do not exclude significant fibrosis, that lean people can develop MASLD/MASH, and that NASH may still appear on FDA labels and older medical records.

The medical community recently updated these names to be more accurate and respectful. This page will help you understand what these new terms mean, why they changed, and what is actually happening inside your liver.

The New Language of Liver Health

In 2023, global liver experts agreed to change the names used for liver conditions related to metabolic health ^[2]. The goal was to move away from “exclusionary” language—defining a disease by what it isn’t (nonalcoholic)—and instead name it for what it is: a condition driven by metabolic factors ^[2].

• MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease): This is the new broad umbrella term for what was previously called NAFLD. It describes a liver that has built up excess fat (steatosis) in the presence of at least one metabolic risk factor, such as high blood pressure, elevated blood sugar, or high cholesterol ^[2][1].
• MASH (Metabolic Dysfunction-Associated Steatohepatitis): This is the new term for NASH. It is a form of MASLD where the fat is accompanied by visible injury and active inflammation in the liver ^[1][3]. It is important to know that MASH activity and fibrosis (scarring) are separate dimensions—you can have active MASH with no scarring, or you could have significant scarring.

A major reason for this shift was to remove “stigmatizing” words. In surveys, many patients and doctors felt that the word “fatty” was insensitive and that “nonalcoholic” focused too much on alcohol rather than the actual cause of the disease ^[2][4]. The new names focus on the metabolic drivers, such as how your body processes energy and insulin ^[2].

What is MASH?

While MASLD simply means there is extra fat in the liver, MASH means that the metabolic stress is actively injuring the liver. To be definitively diagnosed with MASH, three specific features are typically required, which are established histologically (via a biopsy):

1. Steatosis (Fat): The accumulation of fat droplets inside liver cells ^[3].
2. Lobular Inflammation: Your immune system has sent white blood cells into the liver to respond to the stress ^[3][5].
3. Hepatocellular Ballooning: This is a specific type of liver cell injury where the cells swell up and lose their shape, signaling that they are under extreme stress or dying ^[3][5].

Current imaging and blood-based tests (like FibroScan) can estimate the amount of steatosis or the likelihood of advanced fibrosis, but they cannot directly show ballooning or reliably diagnose MASH. Biopsy is the definitive way to establish histologic MASH, although many patients are appropriately managed using non-invasive tests to assess risk without needing a biopsy. Think of MASLD as a liver that is “overcrowded” with fat, while MASH is a liver where that overcrowding has led to a “fire” (inflammation) and “structural damage” (ballooning) ^[6][5].

The Biology: Why Does This Happen?

The primary driver of MASH is metabolic dysfunction, which often starts with insulin resistance ^[7].

Normally, the hormone insulin helps your body use sugar for energy. When you have insulin resistance, your cells don’t respond to insulin properly. This causes your body to pump more fat into the bloodstream, much of which ends up in the liver ^[7][5].

Once the liver is overloaded with fat, a process called lipotoxicity begins:

• Toxic Fat Species: Not all fats are the same. In MASH, the liver begins to create “toxic” types of fats, such as saturated fatty acids and ceramides (a type of waxy fat molecule) ^[8].
• Cellular Stress: These toxic fats act like a slow-acting poison to the liver cells (hepatocytes), damaging their internal machinery ^[5][8].
• The Healing Response: As liver cells are injured (ballooning) and die, the body tries to heal itself by triggering inflammation. If this cycle of injury and inflammation continues over a long period, it can lead to the formation of scar tissue, known as fibrosis ^[9][5].

Why the “Metabolic” Part Matters

By naming the disease MASLD and MASH, doctors are acknowledging that the liver is not an island. It is deeply connected to the rest of your metabolic health. You are more likely to be diagnosed with these conditions if you have:

• Type 2 diabetes or pre-diabetes ^[1].
• Overweight or obesity, particularly around the midsection ^[1].
• High blood pressure (hypertension) ^[2].
• High levels of fats (triglycerides) in your blood ^[2].

Understanding this connection is empowering because it means that managing your overall metabolic health—like your blood sugar and blood pressure—is a direct way to support your liver’s health ^[1]. While a MASH diagnosis can feel overwhelming, it is also a roadmap, pointing toward the specific metabolic factors that you and your care team can focus on together.